Sangani Hospitals Ltd

Sangani Hospitals Ltd

₹ 44.9 0.00%
17 Jul - close price
About

Incorporated in 2021, Sangani Hospitals is in the business of Hospital, Laboratory, and Pharmacy[1]

Key Points

Business Overview:[1][2]
SHL is in the business of Hospitals, pathological laboratory and Pharmacy stores. It operates 2 hospitals viz. Sangani Hospital at Keshod, Gujarat, and Sangani Super Speciality Hospital, Veraval, Gujarat. It also operates 2 pathology laboratories and 2 medical stores.

  • Market Cap 61.9 Cr.
  • Current Price 44.9
  • High / Low 77.0 / 37.0
  • Stock P/E 20.7
  • Book Value 29.8
  • Dividend Yield 0.00 %
  • ROCE 17.4 %
  • ROE 7.76 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Promoter holding has increased by 0.87% over last quarter.
  • Company's working capital requirements have reduced from 37.9 days to 29.3 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 8.36% over last 3 years.
  • Company has high debtors of 210 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026
6 10 8 8 10 11 20 86
4 8 6 6 8 10 19 80
Operating Profit 1 2 2 1 2 1 1 7
OPM % 24% 17% 22% 17% 17% 7% 7% 8%
0 0 0 1 1 1 0 0
Interest 0 0 0 0 0 0 0 0
Depreciation 0 1 0 0 0 0 0 1
Profit before tax 1 1 2 2 2 1 1 6
Tax % 25% 28% 39% 14% 25% 24% 22% 29%
1 1 1 2 2 1 1 3
EPS in Rs 0.86 0.62 0.75 1.20 1.24 0.65 0.73 1.44
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
4 16 16 21 107
3 13 13 19 99
Operating Profit 1 3 3 2 8
OPM % 35% 20% 20% 12% 8%
0 0 1 2 1
Interest 0 0 0 0 0
Depreciation 0 1 0 1 1
Profit before tax 1 2 4 3 8
Tax % 26% 25% 26% 25% 28%
1 2 3 3 4
EPS in Rs 2.66 1.53 1.96 1.88 2.17
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 90%
TTM: 405%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 24%
TTM: 15%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -33%
Return on Equity
10 Years: %
5 Years: 9%
3 Years: 8%
Last Year: 8%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 4 10 14 14 14
Reserves 1 8 20 22 27
0 0 0 0 2
2 2 2 3 71
Total Liabilities 7 20 35 39 114
1 12 13 13 32
CWIP 0 0 0 0 0
Investments 0 0 0 0 4
6 8 23 26 77
Total Assets 7 20 35 39 114

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-0 3 3 2 5
-0 -12 -1 -1 -10
1 11 12 -2 -2
Net Cash Flow 1 1 15 -1 -6
Free Cash Flow -0 -9 2 1 -0
CFO/OP 16% 99% 130% 124% 84%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 203 55 52 51 210
Inventory Days 160 34 51 57 7
Days Payable 455 46 69 51 265
Cash Conversion Cycle -91 43 34 56 -48
Working Capital Days 119 41 38 46 29
ROCE % 18% 14% 10% 17%

Insights

In beta
Mar 2024
Dialysis Patients Served (Cumulative)
patients ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Dialysis Sessions Annually
sessions ・Standalone data
Number of Consulting Doctors
doctors ・Standalone data
Number of Hospitals
hospitals ・Standalone data
Number of Non-Doctor Staff
staff ・Standalone data
Number of Permanent Doctors
doctors ・Standalone data
Total Bed Capacity
beds ・Standalone data
Total Permanent Employees on Payroll
employees ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Sep 2025Mar 2026
72.48% 73.22% 73.22% 73.22% 73.22% 73.22% 73.22% 74.09%
0.00% 0.02% 0.02% 0.02% 0.02% 0.02% 0.00% 0.00%
27.52% 26.76% 26.76% 26.76% 26.76% 26.76% 26.78% 25.91%
No. of Shareholders 555457433431467468431440

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents